DR. JAMES CECIL THOMPSON, DDSPA
Dentist at Chapel Hill Rd, Durham, NC
License number
North Carolina 3232
Category
Dentist
Type
General Practice
Address
Address
1823 Chapel Hill Rd, Durham, NC 27707
Phone
(919) 489-6256
Personal information
See more information about JAMES CECIL THOMPSON at radaris.comName
Address
Phone
2212 Sugar Hill Rd, Marion, NC 28752
2005 Wilshire Dr, Durham, NC 27707
2002 Ashbrook Ct, Leland, NC 28451
200 Round Pond Dr, Hendersonvlle, NC 28739
1998 Ash St SW, Supply, NC 28462
Professional information
Ccr5 Antagonists As Therapeutic Agents
US Patent:
7645771, Jan 12, 2010
Filed:
Dec 12, 2003
Appl. No.:
10/538144
Inventors:
Wieslaw Mieczyslaw Kazmierski - Durham NC, US
Chrisopher Joseph Aquino - Durham NC, US
Neil Bifulco - Durham NC, US
Eric Eugene Boros - Durham NC, US
Brian Andrew Chauder - Durham NC, US
Pek Yoke Chong - Durham NC, US
Maosheng Duan - Durham NC, US
Felix Deanda, Jr. - Durham NC, US
Cecilia Suarez Koble - Durham NC, US
Ed Williams McLean - Durham NC, US
Jennifer Poole Peckham - Durham NC, US
Angilique C Perkins - Durham NC, US
James Benjamin Thompson - Durham NC, US
Dana Vanderwall - Durham NC, US
Chrisopher Joseph Aquino - Durham NC, US
Neil Bifulco - Durham NC, US
Eric Eugene Boros - Durham NC, US
Brian Andrew Chauder - Durham NC, US
Pek Yoke Chong - Durham NC, US
Maosheng Duan - Durham NC, US
Felix Deanda, Jr. - Durham NC, US
Cecilia Suarez Koble - Durham NC, US
Ed Williams McLean - Durham NC, US
Jennifer Poole Peckham - Durham NC, US
Angilique C Perkins - Durham NC, US
James Benjamin Thompson - Durham NC, US
Dana Vanderwall - Durham NC, US
Assignee:
SmithKline Beecham Corp. - Philadelphia PA
International Classification:
A61K 31/46
US Classification:
514304, 514319, 546125, 5483101
Abstract:
The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
James Thompson - Durham, NC
Work:
Domino's Pizza
Assistant Manager
Assistant Manager
Education:
C.E. Jordan Senior High School - Durham, NC
GED
GED
James Thompson - Durham, NC
Work:
Shoney - Lumberton, NC
Bar Corrdinator Labor- Ready Mid Atlantic - Alexandria, VA
Construction laborer Panamovers Transfer Storage - Alexandria, VA
Truck Driver Mazo-Lerch Co - Alexandria, VA
Truck Driver
Bar Corrdinator Labor- Ready Mid Atlantic - Alexandria, VA
Construction laborer Panamovers Transfer Storage - Alexandria, VA
Truck Driver Mazo-Lerch Co - Alexandria, VA
Truck Driver
James Thompson - Durham, NC
Work:
trosa - Durham, NC
crew boss tylers - Durham, NC
line cook { fry/broil}
crew boss tylers - Durham, NC
line cook { fry/broil}
Education:
Trosa lawn care prosfessional program - Durham, NC
Certificate in lawn care OIC OPPORTUNITIES INN - Philadelphia, PA
certificate in culinary arts
Certificate in lawn care OIC OPPORTUNITIES INN - Philadelphia, PA
certificate in culinary arts
James C Thompson, Durham NC
Specialties:
Dentistry
Address:
1823 Chapel Hill Rd, Durham 27707
(919) 489-6256 (Phone)
(919) 489-6256 (Phone)
Languages:
English
Chemical Compounds
US Patent:
8222261, Jul 17, 2012
Filed:
Jan 13, 2009
Appl. No.:
12/373524
Inventors:
Subba R Katamreddy - Durham NC, US
Richard Dama Caldwell - Durham NC, US
Dennis Heyer - Durham NC, US
Vincente Samano - Durham NC, US
James Benjamin Thompson - Durham NC, US
Andrew J Carpenter - Durham NC, US
Christopher R Conlee - Durham NC, US
Eric Eugene Boros - Durham NC, US
Brian D Thompson - Durham NC, US
Richard Dama Caldwell - Durham NC, US
Dennis Heyer - Durham NC, US
Vincente Samano - Durham NC, US
James Benjamin Thompson - Durham NC, US
Andrew J Carpenter - Durham NC, US
Christopher R Conlee - Durham NC, US
Eric Eugene Boros - Durham NC, US
Brian D Thompson - Durham NC, US
Assignee:
GlaxoSmithKline, LLC - Philadelphia PA
International Classification:
A61K 31/519
US Classification:
5142651
Abstract:
The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly Type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.